Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

18F-Flortaucipir in TDP-43 associated frontotemporal dementia.

Smith R, Santillo AF, Waldö ML, Strandberg O, Berron D, Vestberg S, van Westen D, van Swieten J, Honer M, Hansson O.

Sci Rep. 2019 Apr 15;9(1):6082. doi: 10.1038/s41598-019-42625-9.

2.

Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.

Ossenkoppele R, Smith R, Ohlsson T, Strandberg O, Mattsson N, Insel PS, Palmqvist S, Hansson O.

Neurology. 2019 Feb 5;92(6):e601-e612. doi: 10.1212/WNL.0000000000006875. Epub 2019 Jan 9.

3.

Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease.

Vogel JW, Mattsson N, Iturria-Medina Y, Strandberg OT, Schöll M, Dansereau C, Villeneuve S, van der Flier WM, Scheltens P, Bellec P, Evans AC, Hansson O, Ossenkoppele R; Alzheimer's Disease Neuroimaging Initiative; Swedish BioFINDER Study.

Hum Brain Mapp. 2019 Feb 1;40(2):638-651. doi: 10.1002/hbm.24401. Epub 2018 Oct 19.

PMID:
30368979
4.

Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.

Ossenkoppele R, Rabinovici GD, Smith R, Cho H, Schöll M, Strandberg O, Palmqvist S, Mattsson N, Janelidze S, Santillo A, Ohlsson T, Jögi J, Tsai R, La Joie R, Kramer J, Boxer AL, Gorno-Tempini ML, Miller BL, Choi JY, Ryu YH, Lyoo CH, Hansson O.

JAMA. 2018 Sep 18;320(11):1151-1162. doi: 10.1001/jama.2018.12917.

5.

Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease.

Mattsson N, Eriksson O, Lindberg O, Schöll M, Lampinen B, Nilsson M, Insel PS, Lautner R, Strandberg O, van Westen D, Zetterberg H, Blennow K, Palmqvist S, Stomrud E, Hansson O.

Neurobiol Aging. 2018 Nov;71:81-90. doi: 10.1016/j.neurobiolaging.2018.07.003. Epub 2018 Jul 11.

PMID:
30107289
6.

Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort study.

Mattsson N, Ossenkoppele R, Smith R, Strandberg O, Ohlsson T, Jögi J, Palmqvist S, Stomrud E, Hansson O.

Alzheimers Res Ther. 2018 Aug 7;10(1):77. doi: 10.1186/s13195-018-0403-x.

7.

Regional times to equilibria and their impact on semi-quantification of [18F]AV-1451 uptake.

Heurling K, Smith R, Strandberg OT, Schain M, Ohlsson T, Hansson O, Schöll M.

J Cereb Blood Flow Metab. 2018 Aug 3:271678X18791430. doi: 10.1177/0271678X18791430. [Epub ahead of print]

PMID:
30073880
8.

Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease.

Mattsson N, Smith R, Strandberg O, Palmqvist S, Schöll M, Insel PS, Hägerström D, Ohlsson T, Zetterberg H, Blennow K, Jögi J, Hansson O.

Neurology. 2018 Jan 30;90(5):e388-e395. doi: 10.1212/WNL.0000000000004887. Epub 2018 Jan 10.

9.

Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity.

Palmqvist S, Schöll M, Strandberg O, Mattsson N, Stomrud E, Zetterberg H, Blennow K, Landau S, Jagust W, Hansson O.

Nat Commun. 2017 Oct 31;8(1):1214. doi: 10.1038/s41467-017-01150-x.

10.

Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.

Schöll M, Ossenkoppele R, Strandberg O, Palmqvist S; Swedish BioFINDER study, Jögi J, Ohlsson T, Smith R, Hansson O.

Brain. 2017 Sep 1;140(9):2286-2294. doi: 10.1093/brain/awx171.

PMID:
29050382
11.

18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease.

Mattsson N, Schöll M, Strandberg O, Smith R, Palmqvist S, Insel PS, Hägerström D, Ohlsson T, Zetterberg H, Jögi J, Blennow K, Hansson O.

EMBO Mol Med. 2017 Sep;9(9):1212-1223. doi: 10.15252/emmm.201707809.

12.

Modeling Strategies for Quantification of In Vivo 18F-AV-1451 Binding in Patients with Tau Pathology.

Hahn A, Schain M, Erlandsson M, Sjölin P, James GM, Strandberg OT, Hägerström D, Lanzenberger R, Jögi J, Olsson TG, Smith R, Hansson O.

J Nucl Med. 2017 Apr;58(4):623-631. doi: 10.2967/jnumed.116.174508. Epub 2016 Oct 20.

13.

Increased basal ganglia binding of 18 F-AV-1451 in patients with progressive supranuclear palsy.

Smith R, Schain M, Nilsson C, Strandberg O, Olsson T, Hägerström D, Jögi J, Borroni E, Schöll M, Honer M, Hansson O.

Mov Disord. 2017 Jan;32(1):108-114. doi: 10.1002/mds.26813. Epub 2016 Oct 6.

14.

Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.

Voevodskaya O, Sundgren PC, Strandberg O, Zetterberg H, Minthon L, Blennow K, Wahlund LO, Westman E, Hansson O; Swedish BioFINDER study group.

Neurology. 2016 May 10;86(19):1754-61. doi: 10.1212/WNL.0000000000002672. Epub 2016 Apr 15.

15.

Infarction of the small bowel caused by giant cell arteritis. Case report.

Ljungström KG, Strandberg O, Sandstedt B.

Acta Chir Scand. 1989 Jun-Jul;155(6-7):361-3.

PMID:
2816223
16.
17.

Sulphonamide as hemolysis-promoting factor in uremia.

Eklund SG, Johansson SV, Lins LE, Strandberg O.

Scand J Urol Nephrol. 1980;14(3):275-7.

PMID:
7209436
18.

Ferastral in the treatment of patients with inflammatory anaemia.

Strandberg O, Wijnbladh E.

Scand J Haematol Suppl. 1977;32:304-9.

PMID:
341285
19.

Gastrointestinal protein loss in rheumatoid arthritis, studied with 51Cr-chromic chloride and 125I albumin.

Plantin LO, Strandberg O.

Scand J Rheumatol. 1974;3(4):169-73. No abstract available.

PMID:
4617300
20.

Anemia in uremia. Hemolysis evaluated by common methods and application of the bilirubin turnover method.

Eklund SG, Johansson SV, Strandberg O.

Acta Med Scand. 1971 Nov;190(5):435-43. No abstract available.

PMID:
5149271
21.

Anemia in rheumatoid arthritis.

Strandberg O.

Acta Med Scand Suppl. 1966;454:1-153. No abstract available.

PMID:
4287922
22.

[The use of desferrioxamine in iron poisoning and hemosiderosis].

Karlsson B, Lagercrantz R, Brann I, Strandberg O, Reizenstein P.

Nord Med. 1965 Oct 7;74(40):985-8. Swedish. No abstract available.

PMID:
5836665
23.

THE TREATMENT OF NODOSE TENDINITIS IN THE RHEUMATOID HAND.

BAECKDAHL M, STRANDBERG O.

Acta Rheumatol Scand. 1965;11:145-60. No abstract available.

PMID:
14341566
24.

ISOTOPE STUDIES OF THE DISTRIBUTION OF JECTOFER IN PATIENTS WITH RHEUMATOID ARTHRITIS AND IN HEALTH SUBJECTS.

STRANDBERG O.

Acta Rheumatol Scand. 1965;11:19-29. No abstract available.

PMID:
14308107
25.

Is bemegride a specific barbiturate antagonist?

BOTTIGER LE, ENGSTEDT L, STRANDBERG O.

Lancet. 1957 May 4;272(6975):932-3. No abstract available.

PMID:
13417645
26.

[Lung injury through exposure to smoke pot gas].

LINDERHOLM H, STRANDBERG O.

Tidskr Mil Halsov. 1956;81(4):229-41. Swedish. No abstract available.

PMID:
13409361
27.

D2-vitaminterapi ved lupus vulgaris.

STRANDBERG O.

Nord Med. 1948 May 14;38(20):967-71. Undetermined Language. No abstract available.

PMID:
18866465
28.

Treatment of Rhino-laryngological Tuberculosis by Finsen Light Baths, and Results.

Strandberg O.

Proc R Soc Med. 1924;17(Gen Rep):25-30. No abstract available.

Supplemental Content

Loading ...
Support Center